View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Biovian
9 March 2015

Biovian to Attend BIO-Europe Spring 2015

Biovian will attend BIO-Europe Spring 2015 from 9-11 March 2015 in Paris, France.

The company’s CEO, Dr Knut Ringbom will be available for in-depth discussions with delegates at the partnering offered at the conference.

About Biovian

Biovian provides GMP contract manufacturing of biopharmaceuticals covering services from early development to finished vials. The company’s 2300m² facilities are EMA and FDA certified for cGMP production of investigational and commercial products.

Biovian GMP services include:

  • Microbial fermentation
  • Mammalian cell culture
  • Viral vector production
  • Protein purification
  • Formulation
  • Aseptic fill and finish
  • Analytical quality control services
  • Stability studies
  • Master cell banking
  • Drug product labelling, packaging, storage and QP release

Biovian development services include cell line, process and analytical development.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena